BR9910157A - Composição - Google Patents

Composição

Info

Publication number
BR9910157A
BR9910157A BR9910157-2A BR9910157A BR9910157A BR 9910157 A BR9910157 A BR 9910157A BR 9910157 A BR9910157 A BR 9910157A BR 9910157 A BR9910157 A BR 9910157A
Authority
BR
Brazil
Prior art keywords
hepatitis
composition
vaccine compositions
formulations
vaccine
Prior art date
Application number
BR9910157-2A
Other languages
English (en)
Inventor
Claude Artois
Michael J Clark
Chlotilde Thiriart
Stefan Gabriel Jozef Thoelen
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of BR9910157A publication Critical patent/BR9910157A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Patente de Invenção: <B>"COMPOSIçãO"<D>. São proporcionadas novas composições de vacina que compreendem um antígeno da hepatite B formulada com fosfato de alumínio. As composições de vacina podem conter, de forma opcional, um vírus inativado da hepatite A, hidróxido de alumínio e formol. As formulações de vacina combinada da hepatite A e B podem, se desejado, ser administradas a seres humanos em um regime de duas doses. As formulações adequadas são ilustradas.
BR9910157-2A 1998-05-01 1999-04-27 Composição BR9910157A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809507.8A GB9809507D0 (en) 1998-05-01 1998-05-01 Novel composition
PCT/EP1999/003024 WO1999056772A2 (en) 1998-05-01 1999-04-27 Hepatitis vaccine

Publications (1)

Publication Number Publication Date
BR9910157A true BR9910157A (pt) 2001-01-09

Family

ID=10831426

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910157-2A BR9910157A (pt) 1998-05-01 1999-04-27 Composição

Country Status (29)

Country Link
EP (1) EP1073462B1 (pt)
JP (2) JP5138843B2 (pt)
KR (1) KR100612547B1 (pt)
CN (1) CN1263509C (pt)
AR (1) AR016987A1 (pt)
AT (1) ATE345815T1 (pt)
AU (1) AU743759B2 (pt)
BR (1) BR9910157A (pt)
CA (1) CA2331086C (pt)
CO (1) CO5050367A1 (pt)
CY (1) CY1107322T1 (pt)
CZ (1) CZ301232B6 (pt)
DE (1) DE69934108T2 (pt)
DK (1) DK1073462T3 (pt)
ES (1) ES2277437T3 (pt)
GB (1) GB9809507D0 (pt)
GC (1) GC0000101A (pt)
HK (1) HK1034202A1 (pt)
HU (1) HU228209B1 (pt)
IL (1) IL139269A0 (pt)
MY (1) MY128929A (pt)
NO (1) NO20005483L (pt)
NZ (1) NZ507902A (pt)
PL (1) PL190729B1 (pt)
PT (1) PT1073462E (pt)
TR (1) TR200003235T2 (pt)
TW (1) TW553744B (pt)
WO (1) WO1999056772A2 (pt)
ZA (1) ZA200006118B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1513555A (zh) * 2003-07-31 2004-07-21 长春生物制品研究所 甲-乙型肝炎联合疫苗及其冻干制剂
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
CN102198270B (zh) * 2011-05-16 2012-06-27 大连汉信生物制药有限公司 一种含铝佐剂乙肝疫苗的制备方法
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0349686A (ja) * 1989-07-11 1991-03-04 Smithkline Biologicals Sa レトロウイルスｇａｇ蛋白の真核生物細胞における発現
DK0835663T3 (da) * 1992-05-23 2010-02-01 Glaxosmithkline Biolog Sa Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
WO1997035612A1 (fr) * 1996-03-23 1997-10-02 The Research Foundation For Microbial Diseases Of Osaka University Antigene a fragment fonctionnel de la toxine du tetanos, et vaccin contre le tetanos

Also Published As

Publication number Publication date
MY128929A (en) 2007-02-28
ATE345815T1 (de) 2006-12-15
CZ301232B6 (cs) 2009-12-16
CA2331086C (en) 2010-06-22
NZ507902A (en) 2002-03-28
KR20010043224A (ko) 2001-05-25
HUP0101652A1 (hu) 2001-09-28
PT1073462E (pt) 2007-01-31
CY1107322T1 (el) 2012-11-21
TW553744B (en) 2003-09-21
PL344137A1 (en) 2001-10-08
DK1073462T3 (da) 2007-02-26
DE69934108T2 (de) 2007-04-19
AR016987A1 (es) 2001-08-01
GB9809507D0 (en) 1998-07-01
ZA200006118B (en) 2002-01-30
AU4137999A (en) 1999-11-23
EP1073462B1 (en) 2006-11-22
AU743759B2 (en) 2002-02-07
TR200003235T2 (tr) 2001-03-21
CN1308547A (zh) 2001-08-15
NO20005483D0 (no) 2000-10-31
IL139269A0 (en) 2001-11-25
GC0000101A (en) 2005-06-29
DE69934108D1 (de) 2007-01-04
NO20005483L (no) 2000-12-08
JP2002513771A (ja) 2002-05-14
HU228209B1 (en) 2013-01-28
WO1999056772A2 (en) 1999-11-11
JP5138843B2 (ja) 2013-02-06
CO5050367A1 (es) 2001-06-27
CA2331086A1 (en) 1999-11-11
WO1999056772A3 (en) 2000-02-03
ES2277437T3 (es) 2007-07-01
EP1073462A2 (en) 2001-02-07
PL190729B1 (pl) 2005-12-30
HUP0101652A3 (en) 2004-10-28
CZ20004061A3 (cs) 2001-04-11
KR100612547B1 (ko) 2006-08-11
JP2010209118A (ja) 2010-09-24
HK1034202A1 (en) 2001-10-19
CN1263509C (zh) 2006-07-12

Similar Documents

Publication Publication Date Title
CO5210894A1 (es) Composiciones adyudantes que comprenden una sal de aluminio y un inmunoestimulante
TR200002299T2 (tr) Epotilon kompozisyonları.
CY1113078T1 (el) Συνθεση πολυσθενους εμβολιου
IL106968A0 (en) Potentiation of immunogenic response
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
NO20005051L (no) Adjuvantsammensetninger
NZ323973A (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
DE60206137D1 (de) Kräuterpflanzen enthaltende artzneimittel
HK1044484A1 (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide.
DE60121136D1 (de) Proteasom-influenzavirus-impfstoffzusammensetzung
AU2001295673A1 (en) Vaccine composition
MX9401225A (es) Composicion de vacuna para prevenir la infeccion con influenza en humanos y metodo para su preparacion.
ES2162067T3 (es) Composicion de vacuna anti-haemophilus influenzae de tipo b que comprende poli-ribosil-ribitol-fosfato y su procedimiento de preparacion.
DE60143363D1 (de) Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern
BR0010682A (pt) Novas composições
BR9910157A (pt) Composição
WO2002032378A3 (en) Fusion cells and cytokine compositions for treatment of disease
SV1998000040A (es) Composiciones farmaceuticas ref. pu3210/sv
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
AR038311A1 (es) Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes
BR0211181A (pt) Formulação vacinal
EP0952771A4 (en) SAPONIN COMPOSITIONS AND THEIR USE
BR0013574A (pt) Antìgeno vacina de moraxella
BR0009051A (pt) Utilização de uma fração de membrana de klebsiella pneumoniae associada a um antìgeno ou hapteno, e, composição farmacêutica
UY27621A1 (es) &#34; antígeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes&#34;

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 37, 8O E 13 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.